OBJECTIVES: To determine whether patients presenting with a first transient ischaemic attack (TIA) subsequently show increased rates of brain atrophy compared with age matched controls; and to assess potential risk factors for brain atrophy in this group. METHODS: 60 patients with a first, isolated TIA and 26 age and sex matched controls were recruited. None had evidence of cognitive impairment. Vascular risk factors were treated appropriately. All subjects had volumetric imaging at the start of the study and one year later, when they were clinically reassessed. TIA patients also had serial dual echo brain imaging. Rates of whole brain atrophy were calculated from the registered volumetric scans, as was the incidence of new ischaemic lesions. In the TIA group, the degree of white matter disease was assessed. Atrophy rates and blood pressure were compared between patients and controls. RESULTS: 22 patients (37%) developed new "clinically silent" infarcts during follow up. The mean (SD) annualised percentage atrophy rate in the TIA group was significantly higher than in the controls, at 0.82 (0.39)% v 0.33 (0.3)% (p < 0.0001). In the TIA group, diastolic blood pressure (p = 0.004) and white matter disease severity (p < 0.001) were correlated with cerebral atrophy rate. Increased white matter disease was found in patients in whom new ischaemic lesions developed (p < 0.001). CONCLUSIONS: Patients presenting with a first TIA have excess global brain atrophy compared with age matched controls over the subsequent year. Increased atrophy rates following a TIA may be directly or indirectly related to increasing white matter disease and diastolic hypertension. Future studies should assess whether this atrophy inevitably leads to cognitive decline, and whether aggressive treatment of risk factors for cerebrovascular disease (particularly hypertension) after a TIA can influence outcome.
OBJECTIVES: To determine whether patients presenting with a first transient ischaemic attack (TIA) subsequently show increased rates of brain atrophy compared with age matched controls; and to assess potential risk factors for brain atrophy in this group. METHODS: 60 patients with a first, isolated TIA and 26 age and sex matched controls were recruited. None had evidence of cognitive impairment. Vascular risk factors were treated appropriately. All subjects had volumetric imaging at the start of the study and one year later, when they were clinically reassessed. TIA patients also had serial dual echo brain imaging. Rates of whole brain atrophy were calculated from the registered volumetric scans, as was the incidence of new ischaemic lesions. In the TIA group, the degree of white matter disease was assessed. Atrophy rates and blood pressure were compared between patients and controls. RESULTS: 22 patients (37%) developed new "clinically silent" infarcts during follow up. The mean (SD) annualised percentage atrophy rate in the TIA group was significantly higher than in the controls, at 0.82 (0.39)% v 0.33 (0.3)% (p < 0.0001). In the TIA group, diastolic blood pressure (p = 0.004) and white matter disease severity (p < 0.001) were correlated with cerebral atrophy rate. Increased white matter disease was found in patients in whom new ischaemic lesions developed (p < 0.001). CONCLUSIONS: Patients presenting with a first TIA have excess global brain atrophy compared with age matched controls over the subsequent year. Increased atrophy rates following a TIA may be directly or indirectly related to increasing white matter disease and diastolic hypertension. Future studies should assess whether this atrophy inevitably leads to cognitive decline, and whether aggressive treatment of risk factors for cerebrovascular disease (particularly hypertension) after a TIA can influence outcome.
Authors: F-E de Leeuw; J C de Groot; M Oudkerk; J C M Witteman; A Hofman; J van Gijn; M M B Breteler Journal: Brain Date: 2002-04 Impact factor: 13.501
Authors: M Kivipelto; E L Helkala; M P Laakso; T Hänninen; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen Journal: BMJ Date: 2001-06-16
Authors: J T O'Brien; S Paling; R Barber; E D Williams; C Ballard; I G McKeith; A Gholkar; W R Crum; M N Rossor; N C Fox Journal: Neurology Date: 2001-05-22 Impact factor: 9.910
Authors: S M Resnick; A F Goldszal; C Davatzikos; S Golski; M A Kraut; E J Metter; R N Bryan; A B Zonderman Journal: Cereb Cortex Date: 2000-05 Impact factor: 5.357
Authors: H Koga; T Yuzuriha; H Yao; K Endo; S Hiejima; Y Takashima; F Sadanaga; T Matsumoto; A Uchino; K Ogomori; A Ichimiya; H Uchimura; N Tashiro Journal: J Neurol Neurosurg Psychiatry Date: 2002-06 Impact factor: 10.154
Authors: Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox Journal: Proc Natl Acad Sci U S A Date: 2002-04-02 Impact factor: 11.205
Authors: Guangliang Ding; Quan Jiang; Lian Li; Li Zhang; Ying Wang; Zheng Gang Zhang; Mei Lu; Swayamprava Panda; Qingjiang Li; James R Ewing; Michael Chopp Journal: J Neurosci Res Date: 2010-11-01 Impact factor: 4.164
Authors: Wai Kwong Tang; Sandra S M Chan; Helen F K Chiu; Gabor S Ungvari; Ka Sing Wong; Timothy C Y Kwok Journal: J Neurol Date: 2004-07 Impact factor: 4.849
Authors: Silvia Marino; Walter Borsini; Susanna Buchner; Marzia Mortilla; Maria L Stromillo; Marco Battaglini; Antonio Giorgio; Placido Bramanti; Antonio Federico; Nicola De Stefano Journal: J Neurol Date: 2006-03-20 Impact factor: 4.849
Authors: Michael J Firbank; Rebecca M Wiseman; Emma J Burton; Brian K Saxby; John T O'Brien; Gary A Ford Journal: J Neurol Date: 2007-04-20 Impact factor: 4.849
Authors: Quan Jiang; Christine Thiffault; Brian C Kramer; Guang Liang Ding; Li Zhang; Siamak P Nejad-Davarani; Lian Li; Ali S Arbab; Mei Lu; Brad Navia; Stephen J Victor; Klaudyne Hong; Qing Jiang Li; Shi Yang Wang; Yi Li; Michael Chopp Journal: PLoS One Date: 2012-08-10 Impact factor: 3.240
Authors: William R Crum; Michel Modo; Anthony C Vernon; Gareth J Barker; Steven C R Williams Journal: J Neurosci Methods Date: 2013-04-01 Impact factor: 2.390
Authors: William R Crum; Vincent P Giampietro; Edward J Smith; Natalia Gorenkova; R Paul Stroemer; Michel Modo Journal: J Neurosci Methods Date: 2013-05-29 Impact factor: 2.390